Purdue Pharma L.P. et al v. Accord Healthcare Inc.

  1. April 11, 2023

    Purdue Loses Case To Stop Generic OxyContin

    The bankrupt Purdue Pharma lost its legal effort to use patent laws to block an Indian drugmaker from launching a generic version of OxyContin when a federal judge in Delaware decided on Tuesday that some of the patents covering the drug's newer "abuse-deterrent" features could be found in decade-old academic articles and patent paperwork.

  2. September 15, 2022

    IP Forecast: PTAB To Eye Patent Tied To Intel's $2.2B Loss

    The Patent Trial and Appeal Board next week will dive into a controversial legal effort to wipe out claims in a microchip patent tied to part of a $2.18 billion jury verdict against Intel that's being closely watched by the tech industry, lawmakers and the patent office's director. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.